Zurich Cantonal Bank’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Buy |
13,259
+1,911
| +17% | +$83.4K | ﹤0.01% | 1570 |
|
|
2025
Q1 | $311K | Sell |
11,348
-606
| -5% | -$16.6K | ﹤0.01% | 1874 |
|
|
2024
Q4 | $481K | Buy |
11,954
+665
| +6% | +$26.8K | ﹤0.01% | 1655 |
|
|
2024
Q3 | $534K | Buy |
11,289
+915
| +9% | +$43.3K | ﹤0.01% | 1520 |
|
|
2024
Q2 | $310K | Sell |
10,374
-1
| -0% | -$30 | ﹤0.01% | 1810 |
|
|
2024
Q1 | $417K | Buy |
10,375
+4,335
| +72% | +$174K | ﹤0.01% | 1596 |
|
|
2023
Q4 | $154K | Hold |
6,040
| – | – | ﹤0.01% | 2232 |
|
|
2023
Q3 | $84K | Hold |
6,040
| – | – | ﹤0.01% | 2431 |
|
|
2023
Q2 | $139K | Hold |
6,040
| – | – | ﹤0.01% | 2153 |
|
|
2023
Q1 | $179K | Buy |
6,040
+1,055
| +21% | +$31.3K | ﹤0.01% | 1944 |
|
|
2022
Q4 | $124K | Buy |
4,985
+1,225
| +33% | +$30.6K | ﹤0.01% | 2138 |
|
|
2022
Q3 | $82K | Hold |
3,760
| – | – | ﹤0.01% | 2369 |
|
|
2022
Q2 | $74K | Hold |
3,760
| – | – | ﹤0.01% | 2431 |
|
|
2022
Q1 | $159K | Buy |
3,760
+488
| +15% | +$20.6K | ﹤0.01% | 2037 |
|
|
2021
Q4 | $208K | Buy |
3,272
+1,467
| +81% | +$93.3K | ﹤0.01% | 2042 |
|
|
2021
Q3 | $106K | Buy |
+1,805
| New | +$106K | ﹤0.01% | 2307 |
|